Clinical Trials Browser

Phase 1/2 × Lymphoma, B-Cell × Granulocyte Colony-Stimulating Factor × Clear all

NCT00379574 2013-03-15

Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

Phase 1/2 Completed

49 enrolled 8 charts

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse